LABA/LAMA vs LABA plus inhaled corticosteroid (ICS)
Pneumonia · stable COPD
Long‐acting muscarinic antagonist (LAMA) plus long‐acting… leads to lower pneumonia compared with LABA plus inhaled corticosteroid (ICS) (high certainty).
1 finding from 1 review
- Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) versus LABA plus inhaled corticosteroid… 2023 · Cochrane Headline outcomes onlyOR 0.61 [0.52, 0.72]14 studies · 21829 participantsHigh